Roman Dolidze Suspended For One Year Prior to Making UFC Debut

Roman Dolidze Suspended For One Year Prior to Making UFC Debut





Original Source


Prospective
Ultimate Fighting Championship
light heavyweight Roman
Dolidze
has been shut down for a year before ever setting foot
inside the Octagon.

The
U.S. Anti-Doping Agency announced
on Friday that Dolidze tested
positive for multiple substances, and accepted a one-year
suspension following those test results. The Ukrainian tested
positive for clomiphene and “a long-term metabolite of
dehydrochlormethyltestosterone (DHCMT),
4-chloro-18-nor-17β-hydroxymethyl,17α-methyl-5α-androst-13-en-3α-ol
(M3).” Due to his cooperation and willingness to work with the drug
testing agency, his suspension was reduced from a potentially
longer period down to one year. He will be eligible to active
competition in March 2020, dating retroactively to his positive
test earlier this year.

Originally set to make his UFC debut against Gadzhimurad
Antigulov
at UFC Fight Night 149 in April, Dolidze
withdrew unexpectedly
. He was then
scheduled to face
Vinicius
Moreira
at UFC on ESPN 3 in June, but again withdrew from the
bout for undisclosed reasons. It is unclear at this point whether
the positive test affected his placement on either of those cards,
as the failed out-of-competition test occurred in March.

Dolidze is unbeaten as a professional across six fights, with all
six ending before the final bell. His most recent appearance came
against One
Championship
veteran Michal
Pasternak
, where he became the first fighter to ever knock out
the Polish light heavyweight. Prior to signing with the Las
Vegas-based promotion, Dolidze moved to train at
Jackson-Wink MMA
, where he frequently trains with UFC light
heavyweight king Jon Jones.

USADA’s statement regarding Dolidze is as follows:

USADA announced today that Roman
Dolidze
, of Odessa, Ukraine, has accepted a one-year sanction
for a violation of the UFC® Anti-Doping Policy after testing
positive for prohibited substances.

Dolidze, 31, tested positive for clomiphene and its metabolites M1
and M2, as well as a long-term metabolite of
dehydrochlormethyltestosterone (DHCMT),
4-chloro-18-nor-17β-hydroxymethyl,17α-methyl-5α-androst-13-en-3α-ol
(M3), as the result of an out-of-competition urine sample collected
on March 12, 2019. Clomiphene is a Specified Substance in the
category of Hormone and Metabolic Modulators, while DHCMT is a
non-Specified Substance in the class of Anabolic Agents. Both
substances are prohibited at all times under the UFC Anti-Doping
Policy, which has adopted the World Anti-Doping Agency (WADA)
Prohibited List.

Dolidze immediately came forward with detailed evidence of his use
of prohibited substances before entering the UFC Anti-Doping
Program and continued to cooperate throughout USADA’s investigation
related to his use. Based on the specific details of the case,
Dolidze received a reduction from otherwise applicable period of
ineligibility.

Dolidze’ one-year period of ineligibility began on March 12, 2019,
the date his positive sample was collected.








Subscribe To Sky-News

* indicates required



Follow us on Twitter